News & Events:RMD

Resmed Inc (RMD): * RESMED (RMD)- ON JUNE 29 CO ENTERED INTO A CERTAIN SECOND AMENDED AND RESTATED CREDIT AGREEMENT. * Resmed Inc (RMD)- REVOLVING CREDIT AGREEMENT PROVIDES CO REVOLVING CREDIT FACILITY IN AN AGGREGATE AMOUNT OF $1.5 BILLION. * Resmed Inc (RMD)- REVOLVING CREDIT AGREEMENT TERMINATES ON JUNE 29, 2027.

SAN DIEGO, June 28, 2022 -- ResMed (RMD) today announced the promotion of Lucile Blaise to President of Sleep & Respiratory Care, effective July 1, 2022. Blaise, currently ResMed’s Vice President of Sleep & Respiratory Care for Western Europe, is a medtech industry thought leader with over 25 years’ experience in medical device sales, marketing, finance, and business development.

ResMed's short percent of float has risen 5.62% since its last report. Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock.

ResMed has outperformed the market over the past 15 years by 9.9% on an annualized basis producing an average annual return of 16.19%. Currently, ResMed has a market capitalization of $29.81 billion. Buying $1000 In RMD: If an investor had bought $1000 of RMD stock 15 years ago, it would be worth $9,426.23 today based on a price of $203.79 for RMD at the time of writing.

* Futures up: Dow 0.39%, S&P 0.59%, Nasdaq 0.91% * Oracle rises as sales, profit top estimates on cloud boom. * Continental Resources (CLR) jumps on buyout proposal from founder. By Anisha Sircar.

ResMed Strengthens Its Out-Of-Hospital Software Solutions Position With Latest Acquisition - Read How

* Futures up: Dow 0.34%, S&P 0.54%, Nasdaq 0.87% U.S. stock index futures pointed to a potential rebound on Wall Street on Tuesday after a sharp selloff in the previous session pushed the S&P 500 into bear market territory.

The following bids, mergers, ** Medical equipment maker ResMed Inc (RMD) said it will buy German healthcare software provider MEDIFOX DAN GmbH in a $1 billion deal to expand in software-as-a-service outside the United States.

Medical equipment maker ResMed Inc (RMD) said on Tuesday it will buy German healthcare software provider MEDIFOX DAN GmbH in a $1 billion deal to expand in software-as-a-service outside the United States. MEDIFOX, owned by private-equity firm Hg, is a provider of software to more than 6,000 ambulatory care services, care homes and therapists in Germany, according to the latter's website.

U.S. medical equipment maker Resmed Inc (RMD) said on Tuesday it will acquire German healthcare software provider MEDIFOX DAN for $1 billion.

Resmed Inc (RMD): * RESMED TO ACQUIRE MEDIFOX DAN, A GERMAN LEADER IN OUT-OF-HOSPITAL SOFTWARE SOLUTIONS. * SAYS PURCHASE PRICE OF APPROXIMATELY US$1 BILLION. * UPON CLOSING, ACQUISITION EXPECTED TO BE ACCRETIVE TO RESMED'S NON-GAAP DILUTED EARNINGS PER SHARE. * INTENDS TO RETAIN MEDIFOX DAN'S EMPLOYEES, MANAGEMENT STRUCTURE, LOCATIONS, AND BUSINESS PROCESSES.

SAN DIEGO and HILDESHEIM, Germany, June 14, 2022 -- ResMed (RMD) today announced a definitive agreement to acquire privately held MEDIFOX DAN, a German leader in out-of-hospital software solutions for providers in major settings across the care continuum, from Hg, a leading software and services investor.

ResMed (RMD) today announced Mick Farrell, chief executive officer, will participate in a fireside chat at the Goldman Sachs Global Healthcare Conference on Tuesday, June 14, 2022, beginning at approximately 1:20 p.m. at the Terranea Resort in Rancho Palos Verdes, California.

Analysts have provided the following ratings for ResMed within the last quarter: According to 4 analyst offering 12-month price targets in the last 3 months, ResMed has an average price target of $258.25 with a high of $280.00 and a low of $233.00. Below is a summary of how these 4 analysts rated ResMed over the past 3 months.

For Ryder System Inc, Wolfe Research upgraded the previous rating of Underperform to Peer Perform. According to B of A Securities, the prior rating for CAE Inc was changed from Underperform to Neutral. For Ardagh Metal Packaging SA, Barclays upgraded the previous rating of Equal-Weight to Overweight. According to Edward Jones, the prior rating for American Express Co was changed from Hold to Buy.

Check out this: Insiders Buy Around $10M Of 3 Stocks Don't forget to check out our premarket coverage here .

Pre-open movers U.S. stock futures traded higher in early pre-market trade after the Nasdaq tumbled over 300 points in the previous session despite better-than-expected jobs report for May. Futures for the Dow Jones Industrial Average jumped 236 points to 33,124.00 while the Standard & Poor's 500 index futures rose 39.25 points to 4,146.25. Futures for the Nasdaq index climbed 160 points to 12,...

ResMed has outperformed the market over the past 5 years by 12.16% on an annualized basis producing an average annual return of 23.39%. Currently, ResMed has a market capitalization of $30.35 billion. Buying $100 In RMD: If an investor had bought $100 of RMD stock 5 years ago, it would be worth $285.18 today based on a price of $207.47 for RMD at the time of writing.

ResMed (RMD) today announced Rob Douglas, president and chief operating officer, will present at the William Blair Growth Stock Conference on Wednesday, June 8, 2022, beginning at approximately 9:20 a.m. at the Loews Chicago Hotel in Chicago.

ResMed (RMD) today announced Mick Farrell, chief executive officer, will participate in a fireside chat at the Bernstein Strategic Decisions Conference on Wednesday, June 1, 2022, beginning at approximately 1:30 p.m. at the New York Hilton Midtown in New York City.